Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 615 of 6351
-
Can a Low-Dose ketamine infusion lift depression in the ICU?
Symptom relief Stopped earlyThe purpose of this research is to study the effects of intravenous ketamine infusions for the treatment of patients with depressive symptoms in intensive care unit (ICU).
Phase 2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Magnetic pulses may clear long COVID brain fog
Symptom relief Recruiting nowThe goal of this clinical trial is to test whether a type of rapid outpatient brain stimulation that uses magnetic fields, called accelerated intermittent theta burst stimulation (iTBS), can treat symptoms such as brain fog, depression, and anxiety in patients with Long COVID. Th…
Phase 2 • Sponsor: University of New Mexico • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Can a wider biopsy needle sharpen prostate cancer diagnosis?
Diagnosis Recruiting nowProstate biopsy is the definitive examination to establish the diagnosis of prostate cancer, but up to 40% of these biopsies overestimate or underestimate the severity of the disease. A novel biopsy needle system captures substantially more tissue than standard of care needles, b…
Sponsor: Uro-1 Medical • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Can a smarter drainage tube stop a deadly leak after rectal cancer surgery?
Disease control Recruiting nowSurgical resection remains the primary treatment for rectal cancer, but the postoperative incidence of anastomotic leakage (AL) is relatively high. AL not only increases the medical burden on patients, prolongs hospital stays, raises the need for secondary surgery, and elevates p…
Sponsor: Third Military Medical University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New combo therapy aims to tackle Hard-to-Treat lung cancer
Disease control Recruiting nowThis study is an open-label, randomized, controlled, multicenter Phase IIIb clinical study, aiming to evaluate the efficacy, safety, and tolerability of Vebreltinib Enteric Capsule combined with platinum-based doublet chemotherapy compared with platinum-based doublet chemotherapy…
Phase 3 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a VR goggle tour of the operating room calm nerves before surgery?
Symptom relief CompletedThis study evaluated the effect of an operating room introduction using virtual reality (VR) on anxiety, surgical fear, patient satisfaction, postoperative pain, and physiological parameters in patients undergoing arthroscopic orthopedic surgery. The intervention consisted of a …
Sponsor: Acibadem University • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New combo therapy aims to slow prostate cancer spread
Disease control OngoingThis Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone compared with an androgen receptor pathway inhibitor (ARPI, abiraterone or enzalutamide) in participants …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could light replace the Dentist's needle for kids?
Symptom relief Recruiting nowThe purpose of this study is to test photobiomodulation (PBM) with a non-invasive light device for reducing discomfort during dental treatments in children. We plan to conduct a series of three clinical studies in 200 school-aged children requiring routine dental treatment. The f…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Gene therapy eye drops aim to heal corneas in rare nerve disorder
Disease control Recruiting nowThe Sponsor is developing KB801, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector engineered to deliver functional full-length human nerve growth factor (NGF) to the corneas of people with Stage 2 or 3 neurotrophic keratitis (NK) via top…
Phase 1/2 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a patch of the Eye's own tissue seal stubborn macular holes?
Disease control CompletedThis prospective interventional clinical trial aims to evaluate the anatomical and functional outcomes of autologous Tenon's capsule autograft in the surgical management of large and recurrent full-thickness macular holes. Patients with large (\>400 µm), chronic, recurrent, or hi…
Sponsor: Benha University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug INV-6452 targets Hard-to-Treat breast cancers
Disease control Recruiting nowThis is a Phase 1 and Phase 2 study to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of INV-6452 in adult patients with Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) advanced/metastatic breast ca…
Phase 1/2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Triple threat before surgery: could this combo shrink lung tumors better?
Disease control Recruiting nowThis phase II study aims to evaluate the efficacy and safety of low-dose radiation + SBRT + Tislelizumab plus platinum-based chemotherapy as neoadjuvant therapy for stage II-III non-small cell lung cancer.
Phase 2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
A 30-Second ultrasound trick that could spot deadly blood clots?
Diagnosis CompletedThe study will be multi-centre and prospectively planned. All patients who undergo contrast-enhanced computed tomography in the emergency department with a preliminary diagnosis of pulmonary embolism and who do not meet the exclusion criteria will be included in the study. Inform…
Sponsor: Recep Tayyip Erdogan University Training and Research Hospital • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
New hope for tough prostate cancer: drug combo trial launches
Disease control OngoingThis Phase II study aims to evaluate the efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg QD doses + lutetium (177Lu) vipivotide tetraxetan (hereafter referred as AAA617) compared with AAA617 (control) in participants with meta…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Race against time: does immediate carotid surgery cut stroke risk?
Disease control Recruiting nowIn patients with internal carotid artery (ICA) stenosis of 50% or greater (measured according to the criteria of the North American Symptomatic Carotid Endarterectomy Trial (NASCET)) who have experienced a transient ischemic attack (TIA) or minor ipsilateral stroke, carotid endar…
Sponsor: Italian Society of Vascular and Endovascular Surgery • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can a higher dose of xolair beat food allergies?
Disease control Recruiting nowThis research is being conducted to assess the safety and effectiveness of increased dosing of Omalizumab for food allergies.
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo takes on Hard-to-Treat prostate cancer
Disease control Recruiting nowThe purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with metastatic castration-resistant prostate cancer (mCRPC). The goals of this study are to learn about: * The safety of the …
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a shot cure your acne? new mRNA vaccine trial begins
Vaccine Recruiting nowThe purpose of the VBE00009 study is to evaluate the safety, efficacy and immunogenicity of 2 administrations of the Acne mRNA vaccine candidate at single dose level in participants aged 18 to 45 years with mild acne. This study will consist of a Core Study followed by an optiona…
Phase 1/2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jul 11, 2026 00:00 UTC
-
Can a patch make torn shoulder tendons heal stronger?
Disease control Recruiting nowThe overall objective of this clinical investigation is to assess the safety and efficacy of full-thickness arthroscopic rotator cuff repairs augmented with the FiberLocker System for the subjects. The primary outcome of the investigation is to assess the safety after full-thickn…
Sponsor: ZuriMED Technologies AG • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for hard-to-treat myeloma: experimental combo tested in phase 2 trial
Disease control Recruiting nowThis is a single - arm, multi - cohort, open - label, multi - center Phase II clinical study. It aims to evaluate the efficacy and safety of F182112 combined with different administration regimens in patients with relapsed or refractory multiple myeloma.
Phase 2 • Sponsor: Shandong New Time Pharmaceutical Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC